PMC:7589163 / 66857-67257 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T254","span":{"begin":36,"end":73},"obj":"Disease"},{"id":"T255","span":{"begin":58,"end":73},"obj":"Disease"},{"id":"T256","span":{"begin":64,"end":73},"obj":"Disease"}],"attributes":[{"id":"A254","pred":"mondo_id","subj":"T254","obj":"http://purl.obolibrary.org/obo/MONDO_0001577"},{"id":"A255","pred":"mondo_id","subj":"T255","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A256","pred":"mondo_id","subj":"T256","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Bresee JS 1996 [39] ChildrenRCT Vitamin A (50,000 to 200,000 UI, dosed according to age) Not significantly different in the number of days during which supplemental oxygen was required.Not significant difference in the number of days required to achieve normal respiratory rates."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T634","span":{"begin":8,"end":9},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T635","span":{"begin":58,"end":63},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T636","span":{"begin":75,"end":76},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T637","span":{"begin":160,"end":161},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Bresee JS 1996 [39] ChildrenRCT Vitamin A (50,000 to 200,000 UI, dosed according to age) Not significantly different in the number of days during which supplemental oxygen was required.Not significant difference in the number of days required to achieve normal respiratory rates."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T86971","span":{"begin":0,"end":9},"obj":"Chemical"},{"id":"T76882","span":{"begin":0,"end":7},"obj":"Chemical"},{"id":"T303","span":{"begin":152,"end":161},"obj":"Chemical"},{"id":"T62239","span":{"begin":152,"end":159},"obj":"Chemical"},{"id":"T54517","span":{"begin":286,"end":292},"obj":"Chemical"}],"attributes":[{"id":"A59183","pred":"chebi_id","subj":"T86971","obj":"http://purl.obolibrary.org/obo/CHEBI_17336"},{"id":"A74613","pred":"chebi_id","subj":"T76882","obj":"http://purl.obolibrary.org/obo/CHEBI_33229"},{"id":"A31452","pred":"chebi_id","subj":"T303","obj":"http://purl.obolibrary.org/obo/CHEBI_17336"},{"id":"A24974","pred":"chebi_id","subj":"T62239","obj":"http://purl.obolibrary.org/obo/CHEBI_33229"},{"id":"A95724","pred":"chebi_id","subj":"T54517","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"}],"text":"Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Bresee JS 1996 [39] ChildrenRCT Vitamin A (50,000 to 200,000 UI, dosed according to age) Not significantly different in the number of days during which supplemental oxygen was required.Not significant difference in the number of days required to achieve normal respiratory rates."}

{"project":"LitCovid-sentences","denotations":[{"id":"T418","span":{"begin":0,"end":116},"obj":"Sentence"},{"id":"T419","span":{"begin":118,"end":400},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Bresee JS 1996 [39] ChildrenRCT Vitamin A (50,000 to 200,000 UI, dosed according to age) Not significantly different in the number of days during which supplemental oxygen was required.Not significant difference in the number of days required to achieve normal respiratory rates."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2790","span":{"begin":22,"end":30},"obj":"Species"},{"id":"2797","span":{"begin":382,"end":393},"obj":"Species"},{"id":"2806","span":{"begin":0,"end":9},"obj":"Chemical"},{"id":"2807","span":{"begin":286,"end":292},"obj":"Chemical"},{"id":"2826","span":{"begin":36,"end":73},"obj":"Disease"}],"attributes":[{"id":"A2790","pred":"tao:has_database_id","subj":"2790","obj":"Tax:9606"},{"id":"A2797","pred":"tao:has_database_id","subj":"2797","obj":"Tax:12814"},{"id":"A2806","pred":"tao:has_database_id","subj":"2806","obj":"MESH:D014801"},{"id":"A2807","pred":"tao:has_database_id","subj":"2807","obj":"MESH:D010100"},{"id":"A2826","pred":"tao:has_database_id","subj":"2826","obj":"MESH:D018357"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Bresee JS 1996 [39] ChildrenRCT Vitamin A (50,000 to 200,000 UI, dosed according to age) Not significantly different in the number of days during which supplemental oxygen was required.Not significant difference in the number of days required to achieve normal respiratory rates."}